Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

869
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
869

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence.

Journal of current glaucoma practice·2026
Same author

Bridging Genomics and Practice: Rethinking Genetic Counseling in Glaucoma.

Journal of current glaucoma practice·2026
Same author

Evaluating the ease of use and clinical applicability of the Melbourne Rapid Field for visual field testing: A real-world experience.

Indian journal of ophthalmology·2025
Same author

Weighted Quality of Life in Glaucoma Patients with Advanced Disease.

Journal of current glaucoma practice·2025
Same author

Minimally Invasive Glaucoma Surgeries, Health Economics, and the Moral Imperative of Equity in Glaucoma Care.

Journal of current glaucoma practice·2025
Same author

Current perspectives in tackling glaucoma blindness.

Indian journal of ophthalmology·2025
Same journal

Neurofibromatosis Type 1 with Plexiform Neurofibroma: A Novel Mutation Uncovered.

Romanian journal of ophthalmology·2026
Same journal

Isolated Third Nerve Palsy and Alternate Hemiparesis in Brain Stem Stroke: A Case Report.

Romanian journal of ophthalmology·2026
Same journal

Innovations in Corneal Transplantation: The Role of Eye Banks, Donor Corneas, and Artificial Alternatives in Combating Worldwide Corneal Blindness.

Romanian journal of ophthalmology·2026
Same journal

Neural Network - Supported Prognostic Assessment of Apoptotic and Inflammatory Markers in Neovascular Glaucoma.

Romanian journal of ophthalmology·2026
Same journal

Visual Improvement and Optical Quality Changes After Keratoplasty in Macular Corneal Dystrophy in Romania.

Romanian journal of ophthalmology·2026
Same journal

Fat Infiltration in Eyelids: An Uncommon Clinical Case with Long-Term Monitoring.

Romanian journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Dec 14, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K

Evaluating glaucoma surgeries in the MIGS context.

Deepika Dhingra1, Shibal Bhartiya2

  • 1CShah Satnam Ji Speciality Hospitals, Sirsa, Haryana, India.

Romanian Journal of Ophthalmology
|July 21, 2020
PubMed
Summary
This summary is machine-generated.

Glaucoma management poses challenges due to chronic, progressive nature and high treatment costs. Minimally Invasive Glaucoma Surgeries (MIGS) offer a new therapeutic option, requiring careful patient-specific consideration.

Keywords:
MIGSglaucomaglaucoma drainage deviceminimally invasive glaucoma surgerytrabeculectomy

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.5K

Related Experiment Videos

Last Updated: Dec 14, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.5K

Area of Science:

  • Ophthalmology
  • Glaucoma Management
  • Surgical Innovation

Background:

  • Glaucoma presents chronic, progressive, and often asymptomatic challenges.
  • Current medical and surgical treatments can be costly and impact patient quality of life.
  • Minimally Invasive Glaucoma Surgeries (MIGS) represent an evolving therapeutic bridge.

Purpose of the Study:

  • To review the decision-making process for selecting appropriate glaucoma treatments.
  • To highlight the role of MIGS in the current glaucoma surgical armamentarium.
  • To guide clinicians in choosing MIGS based on patient-specific factors.

Main Methods:

  • Literature review of current glaucoma management strategies.
  • Analysis of patient-specific factors influencing treatment choice.
  • Comparison of available Minimally Invasive Glaucoma Surgeries.

Main Results:

  • MIGS offer a spectrum of options for glaucoma treatment.
  • Treatment selection requires careful consideration of patient age, glaucoma type, life expectancy, socioeconomic status, expectations, and comorbidities like cataract.
  • A tailored approach is crucial for optimal patient outcomes.

Conclusions:

  • Effective glaucoma management necessitates personalized treatment strategies.
  • MIGS provide valuable alternatives, but require informed patient-specific decision-making.
  • Integrating patient factors into the choice of MIGS can improve quality of life and treatment adherence.